RTTNews | Feb 18, 2021 09:52AM EST

09:52 Thursday, February 18, 2021 (RTTNews.com) - Shares of Immunome, Inc. (IMNM) are up more than 125% Thursday morning after the company announced the discovery of antibodies capable of neutralizing several SARS-CoV-2 variants, including the South African Variant, in pseudovirus testing.

The company has been working on developing a cocktail of antibodies targeting spike and non-spike proteins that can serve as a treatment for Covid-19.

"As part of developing our antibody cocktail (IMM-BCP-001), Immunome has identified antibodies that bind to non-overlapping regions of the spike protein, including those regions containing the critical mutational variants. Immunome's research shows that certain of our antibodies neutralize pseudoviruses expressing the spike protein of the South African Variant. Recent literature suggests that this South African Variant reduces the effectiveness of certain vaccines and antibody therapies," the company said.

IMNM touched a new high of $61 this morning before sliding to trade at 49 currently.

Read the original article on RTTNews ( https://www.rttnews.com/3170919/stock-alert-immunome-soars-after-discovering-antibodies-that-can-fight-covid-19-variants.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved